Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: In November 2021, our board of directors approved a program for the repurchase of outstanding shares of our common stock with an aggregate purchase amount of up to $10.0 million.
−Removed: Shares may be repurchased under the program from time to time, in amounts and at prices that the Company deems appropriate, subject to market and business conditions, applicable legal requirements and other considerations.
−Removed: The program may be executed using open market purchases pursuant to Rule 10b-18 under the Exchange Act, in privately negotiated agreements, or by way of issuer tender offers, Rule 10b5-1 plans or other transactions.
−Removed: From the inception of the program through September 30, 2024, we have repurchased approximately 298 thousand shares of our common stock for aggregate consideration of approximately $7.6 million.
−Removed: Remaining authorization under this program is $2.4 million.
−Removed: No shares were purchased during the three months ended September 30, 2024.
+Added: Our board of directors approved programs for the repurchase of outstanding shares of our common stock with an aggregate purchase amount of up to $10.0 million (the “November 2021 Program”) and $75.0 million (the “December 2024 Program”), in November 2021 and December 2024, respectively.
+Added: The December 2024 Program replaced the authority granted under the November 2021 Program.
+Added: Shares may be repurchased under the December 2024 Program from time to time, in amounts and at prices that the Company deems appropriate, subject to market and business conditions, applicable legal requirements and other considerations.
+Added: The December 2024 Program may be executed using open market purchases pursuant to Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”), in privately negotiated agreements or by way of issuer tender offers, Rule 10b5-1 plans or other transactions.
+Added: From the inception of the November 2021 Program through March 31, 2025, we have repurchased approximately 403 thousand shares of our common stock for aggregate consideration of approximately $9.6 million.
+Added: Remaining authorization under the December 2024 Program is $73.0 million.
+Added: The following table is a summary of our repurchases of our common stock during the three months ended March 31, 2025.
+Added: Period Total number of shares purchased (a) Average price paid per share Total number of shares purchased as part of publicly announced plan or programs (a) Maximum value of shares that may yet be purchased under the plan or program (in thousands) (a)
+Added: January 1, 2025 - January 31, 2025 105,253 $ 18.97 105,253 $ 73,003
+Added: February 1, 2025 - February 28, 2025 — $ — — 73,003
+Added: March 1, 2025 - March 31, 2025 — $ — — 73,003
+Added: Total 105,253 $ 18.97 105,253
Defaults Upon Senior Securities
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.